2025 annual financial data
Drugs Made In America Acquisition 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -2,816,013 USD and net income was 5,940,643 USD.
Operating cash flow was -539,187 USD.
Get free Drugs Made In America Acquisition email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -2,816,013 USD
- Net income
- 5,940,643 USD
- Operating cash flow
- -539,187 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Drugs Made In America Acquisition financial years